Inform Cancer Center

Some of the most common breast cancer drugs used in chemotherapy, hormonal therapy and biological therapy. Drugs in the chemotherapy regimen intended to stop further proliferation of cancer cells. They include drugs such as Flurouracil, Epurubicin, Clyclophosphamide, Adrriamycin methotrexate and Mitozantrone among others. Some of these cancer treatments used in combination to the patient the maximum benefit. The most common side effects experienced when the chemotherapy drugs used include hair loss, nausea, early menopause, fatigue, hot flashes, and temporary low blood counts. After completion of treatment is achieved, however, most of these side effects disappear. Some, such as menopause, however, is permanent.

Hormone therapy involves the use of cancer drugs such as tamoxifen, Arimidex, Femara and Aromasin. Tamoxifen is used specifically in pre-menopausal women, while the Arimidex, Femara and Aromasin applied to post-menopausal women. Drugs administered under the regimen of hormone therapy prevents cancer cells from growing by preventing the release of the hormone estrogen in tijelu.Hormonska drug therapy is often used after breast cancer surgery to prevent further growth of cancer cells in the breast. Taxol is another cancer drug that belongs to the hormone inhibiting kategoriji.Droga specially administered to patients who received Adriamycin chemotherapy. Some of the noted side effects of drugs used in hormone therapy regime is manifested by vaginal dryness and hot flashes. When Taxol is used, patients may experience tingling or numbness in the legs and arms, and muscular pain. Painful joints are also a common complaint among patients receiving Taxol therapy. Other drugs such as Herceptin decreased biological therapy regimen. Drugs in this category work by stimulating the immune system pacijenta.Imunološki system in turn acts by destroying existing cancer cells.

a certain type of breast cancer drugs that will be used to determine each patient's oncologist on the basis of the patient. Depending on patient age, health, resistance to certain cancer treatments and stage of cancer, the oncologist may recommend a variety or combination of treatments for breast cancer. Notably, however, the list of cancer drugs will continue to grow in the coming days, especially as researchers continue to explore newer and more effective treatments. Patients can also benefit from the recent discovery of the drug through participation in clinical trials.